This inventor holds 1 USPTO granted patent. Top assignee: National Taiwan University. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Yi-Jiun Pan: Innovator in Serotype Identification
Introduction
Yi-Jiun Pan is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of serotype identification through innovative methods that enhance clinical diagnostics. His work focuses on improving the specificity and sensitivity of identifying serotypes, particularly through the use of polymerase chain reaction (PCR) techniques.
Latest Patents
Yi-Jiun Pan holds a patent related to a method of identifying a serotype. This invention utilizes specific PCR primer sets designed according to a fragment of a capsular polysaccharide synthesis (cps) region. The method is particularly aimed at identifying the K57 or NTUH-N1 serotype, with NTUH-N1 being a novel serotype that differs from the previously reported 77 serotypes. This PCR-based cps genotyping method addresses the limitations of conventional immune methods, offering advantages such as rapidity and low cost. Additionally, it reduces the rate of unidentifiable strains, making it a valuable tool in clinical diagnostics. He has 1 patent to his name.
Career Highlights
Yi-Jiun Pan is affiliated with National Taiwan University, where he continues to engage in research and development in the field of serotype identification. His work has garnered attention for its practical applications in clinical settings, showcasing his commitment to advancing medical diagnostics.
Collaborations
He has collaborated with notable colleagues, including Han-Chi Fang and Jin-Town Wang, contributing to the advancement of research in his field.
Conclusion
Yi-Jiun Pan's innovative approach to serotype identification through PCR technology represents a significant advancement in clinical diagnostics. His contributions are paving the way for more effective and efficient methods in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
